Methods of altering bone growth by administration of sost or wise antagonist or agonist
AssigneeOssifi-Mab LLC
InventorDebra L. ELLIES
Life of this patent
Estimating the term…
Loading patent…
AssigneeOssifi-Mab LLC
InventorDebra L. ELLIES
Estimating the term…
The present invention provides a method of promoting local bone growth by administering a therapeutic amount of a Sost antagonist to a mammalian patient in need thereof. Preferably, the Sost antagonist is an antibody or FAB fragment selectively recognizing any one of SEQ ID NOS:1-23. The Sost antagonist may becoadministered together or sequentially with a matrix conducive to anchoring new bone growth. Orthopedic and Periodontal devices comprising an implantable portion adapted to be permanently implanted within a mammalian body and bearing an external coating of a Sost antagonist are also disclosed, as it a method ofincreasing bone density by administering to a mammalian patient a therapeutic amount of a Sost antagonist together with an antiresorptive drug.
A method for increasing bone density in a human subject-treated with a means for binding to human sclerostin (SOST) protein, the method comprising administration to the subject of an antiresorptive drug.
A method for increasing bone density in a human subject treated with an antiresorptive drug, the method comprising administration to the subject of a means for binding to human SOST protein.
A method for increasing bone density in a human subject, the method comprising (1) administration to the subject of a means for binding to human SOST protein;
Dependencies are inferred from the claim text.